Elevated serum progastrin-releasing peptide (31–98) level is a predictor of short response duration after hormonal therapy in metastatic prostate cancer
Masahiro Yashi, Akinori Nukui, Shinsuke Kurokawa, Masanori Ochi, Shinya Ishikawa, Kentaro Goto, Yutaka Kobayashi, Osamu Muraishi, Akihiko TokueVolume:
56
Year:
2003
Language:
english
Pages:
8
DOI:
10.1002/pros.10260
File:
PDF, 135 KB
english, 2003